J. Ferte et al., Flavonoid-related modulators of multidrug resistance: Synthesis, pharmacological activity, and structure-activity relationships, J MED CHEM, 42(3), 1999, pp. 478-489
A series of 28 flavonoid derivatives containing a N-benzylpiperazine chain
have been synthesized and tested for their ability to modulate multidrug re
sistance (MDR) in vitro. At 5 mu M, most compounds potentiated doxorubicin
cytotoxicity on resistant K562/DOX cells. They were also able to increase t
he intracellular accumulation of JC-1, a fluorescent molecule recently desc
ribed as a probe of P-glycoprotein-mediated MDR. This suggests that these c
ompounds act, at least in part, by inhibiting P-glycoprotein activity. As i
n other studies, lipophilicity was shown to influence MDR-modulating activi
ty but was not the only determinant. Diverse di- and trimethoxy substitutio
ns on N-benzyl were examined and found to affect the activity differently.
The most active compounds had a 2,3,4-trimethoxybenzylpiperazine chain atta
ched to either a flavone or a flavanone moiety (13, 19, 33, and 37) and wer
e found to be more potent; than verapamil.